We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Arrow Acquisition Leads FTC to Propose Asset Divestiture
Arrow Acquisition Leads FTC to Propose Asset Divestiture
December 9, 2009
The FTC has proposed a consent order to ensure competition for two generic drugs after Watson Pharmaceuticals’ acquisition of Arrow Pharmaceuticals.